|
1
|
Casella CR and Mitchell TC: Putting
endotoxin to work for us: monophosphoryl lipid A as a safe and
effective vaccine adjuvant. Cell Mol Life Sci. 65:3231–3240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michaud JP, Hallé M, Lampron A, et al:
Toll-like receptor 4 stimulation with the detoxified ligand
monophosphoryl lipid A improves Alzheimer’s disease-related
pathology. Proc Natl Acad Sci USA. 110:1941–1946. 2013.PubMed/NCBI
|
|
3
|
Steinman RM: The dendritic cell system and
its role in immunogenicity. Annu Rev Immunol. 9:271–296. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar
|
|
5
|
Bronte V and Zanovello P: Regulation of
immune responses by L-arginine metabolism. Nat Rev Immunol.
5:641–654. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rodríguez PC and Ochoa AC: Arginine
regulation by myeloid derived suppressor cells and tolerance in
cancer: mechanisms and therapeutic perspectives. Immunol Rev.
222:180–191. 2008.PubMed/NCBI
|
|
7
|
Youn JI, Nagaraj S, Collazo M and
Gabrilovich DI: Subsets of myeloid-derived suppressor cells in
tumor-bearing mice. J Immunol. 181:5791–5802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kusmartsev S, Nefedova Y, Yoder D and
Gabrilovich DI: Antigen-specific inhibition of CD8+ T
cell response by immature myeloid cells in cancer is mediated by
reactive oxygen species. J Immunol. 172:989–999. 2004.PubMed/NCBI
|
|
9
|
Schmielau J and Finn OJ: Activated
granulocytes and granulocyte-derived hydrogen peroxide are the
underlying mechanism of suppression of t-cell function in advanced
cancer patients. Cancer Res. 61:4756–4760. 2001.
|
|
10
|
Kusmartsev S, Nagaraj S and Gabrilovich
DI: Tumor-associated CD8+ T cell tolerance induced by
bone marrow-derived immature myeloid cells. J Immunol.
175:4583–4592. 2005.PubMed/NCBI
|
|
11
|
Szuster-Ciesielska A, Hryciuk-Umer E,
Stepulak A, Kupisz K and Kandefer-Szerszeń M: Reactive oxygen
species production by blood neutrophils of patients with laryngeal
carcinoma and antioxidative enzyme activity in their blood. Acta
Oncol. 43:252–258. 2004. View Article : Google Scholar
|
|
12
|
Waris G and Ahsan H: Reactive oxygen
species: role in the development of cancer and various chronic
conditions. J Carcinog. 5:142006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mantovani G, Macciò A, Madeddu C, et al:
Antioxidant agents are effective in inducing lymphocyte progression
through cell cycle in advanced cancer patients: assessment of the
most important laboratory indexes of cachexia and oxidative stress.
J Mol Med (Berl). 81:664–673. 2003. View Article : Google Scholar
|
|
14
|
Agostinelli E and Seiler N:
Non-irradiation-derived reactive oxygen species (ROS) and cancer:
therapeutic implications. Amino Acids. 31:341–355. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang R, Cai Z, Zhang Y, Yutzy WH, Roby KF
and Roden RB: CD80 in immune suppression by mouse ovarian
carcinoma-associated Gr-1+CD11b+ myeloid
cells. Cancer Res. 66:6807–6815. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang B, Pan PY, Li Q, et al:
Gr-1+CD115+ immature myeloid suppressor cells
mediate the development of tumor-induced T regulatory cells and
T-cell anergy in tumor-bearing host. Cancer Res. 66:1123–1131.
2006.
|
|
17
|
Lutz MB, Kukutsch NA, Menges M, Rössner S
and Schuler G: Culture of bone marrow cells in GM-CSF plus high
doses of lipopolysaccharide generates exclusively immature
dendritic cells which induce alloantigen-specific CD4 T cell anergy
in vitro. Eur J Immunol. 30:1048–1052. 2000. View Article : Google Scholar
|
|
18
|
Greifenberg V, Ribechini E, Rössner S and
Lutz MB: Myeloid-derived suppressor cell activation by combined LPS
and IFN-gamma treatment impairs DC development. Eur J Immunol.
39:2865–2876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu C, Zhang C, Lu H, et al: Poly(I:C)
induce bone marrow precursor cells into myeloid-derived suppressor
cells. Mol Cell Biochem. 358:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baldridge JR and Crane RT: Monophosphoryl
lipid A (MPL) formulations for the next generation of vaccines.
Methods. 19:103–107. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ulrich JT and Myers KR: Monophosphoryl
lipid A as an adjuvant. Past experiences and new directions. Pharm
Biotechnol. 6:495–524. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsujimoto H, Efron PA, Matsumoto T, et al:
Maturation of murine bone marrow-derived dendritic cells with
poly(I:C) produces altered TLR-9 expression and response to CpG
DNA. Immunol Lett. 107:155–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Tang H, Guo Z, et al: Splenic
stroma drives mature dendritic cells to differentiate into
regulatory dendritic cells. Nat Immunol. 5:1124–1133. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang H, Guo Z, Zhang M, Wang J, Chen G and
Cao X: Endothelial stroma programs hematopoietic stem cells to
differentiate into regulatory dendritic cells through IL-10. Blood.
108:1189–1197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia S, Guo Z, Xu X, Yi H, Wang Q and Cao
X: Hepatic microenvironment programs hematopoietic progenitor
differentiation into regulatory dendritic cells, maintaining liver
tolerance. Blood. 112:3175–3185. 2008. View Article : Google Scholar
|
|
26
|
Li Q, Guo Z, Xu X, Xia S and Cao X:
Pulmonary stromal cells induce the generation of regulatory DC
attenuating T-cell-mediated lung inflammation. Eur J Immunol.
38:2751–2761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sánchez-Sánchez N, Riol-Blanco L and
Rodríguez-Fernández JL: The multiple personalities of the chemokine
receptor CCR7 in dendritic cells. J Immunol. 176:5153–5159.
2006.PubMed/NCBI
|
|
28
|
Pan PY, Wang GX, Yin B, et al: Reversion
of immune tolerance in advanced malignancy: modulation of
myeloid-derived suppressor cell development by blockade of
stem-cell factor function. Blood. 111:219–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sinha P, Clements VK, Fulton AM and
Ostrand-Rosenberg S: Prostaglandin E2 promotes tumor progression by
inducing myeloid-derived suppressor cells. Cancer Res.
67:4507–4513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serafini P, Carbley R, Noonan KA, Tan G,
Bronte V and Borrello I: High-dose granulocyte-macrophage
colony-stimulating factor-producing vaccines impair the immune
response through the recruitment of myeloid suppressor cells.
Cancer Res. 64:6337–6343. 2004. View Article : Google Scholar
|
|
31
|
Bunt SK, Yang L, Sinha P, Clements VK,
Leips J and Ostrand-Rosenberg S: Reduced inflammation in the tumor
microenvironment delays the accumulation of myeloid-derived
suppressor cells and limits tumor progression. Cancer Res.
67:10019–10026. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gabrilovich D, Ishida T, Oyama T, et al:
Vascular endothelial growth factor inhibits the development of
dendritic cells and dramatically affects the differentiation of
multiple hematopoietic lineages in vivo. Blood. 92:4150–4166.
1998.
|
|
33
|
Kusmartsev S and Gabrilovich DI: STAT1
signaling regulates tumor-associated macrophage-mediated T cell
deletion. J Immunol. 174:4880–4891. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Movahedi K, Guilliams M, Van den Bossche
J, et al: Identification of discrete tumor-induced myeloid-derived
suppressor cell subpopulations with distinct T cell-suppressive
activity. Blood. 111:4233–4244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Terabe M, Matsui S, Park JM, et al:
Transforming growth factor-beta production and myeloid cells are an
effector mechanism through which CD1d-restricted T cells block
cytotoxic T lymphocyte-mediated tumor immunosurveillance:
abrogation prevents tumor recurrence. J Exp Med. 198:1741–1752.
2003. View Article : Google Scholar
|
|
36
|
Cluff CW: Monophosphoryl lipid A (MPL) as
an adjuvant for anti-cancer vaccines: clinical results. Adv Exp Med
Biol. 667:111–123. 2010. View Article : Google Scholar
|
|
37
|
Abdi K, Singh NJ and Matzinger P:
Lipopolysaccharide-activated dendritic cells: ‘exhausted’ or alert
and waiting? J Immunol. 188:5981–5989. 2012.
|
